stockrowAvita Medical Inc.
RCEL Healthcare Medical Devices
Avita Medical Inc.’s revenue for fiscal 2025 (year ended December 2025) was $71.6 million, up 11.5% from fiscal 2024.
- Revenue
- +53.1%
- EPS
- +56.9%
- Free cash flow
- +86.7%
- Total debt
- +7.13%
Quarter to September 2026, against a year earlier
Follow RCEL
Alert me
Avita Medical Inc. (RCEL) EV/Sales
As of 5 November 2026, Avita Medical Inc. (RCEL) trades at a EV/Sales of 6.7×. Over the past ten years it has ranged from 0.0× (September 2020) to 32.4× (October 2020); the current reading is higher than 79% of that period. That is above the Medical Devices industry median of 2.7× and above the Healthcare sector median of 3.5×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 2.3× | (56.96%) |
| FY2024 | 5.3× | (10.68%) |
| FY2023 | 5.9× | 145.14% |
| FY2022 | 2.4× | (84.31%) |
| FY2021 | 15.3× | 11.75% |
| FY2021 | 13.7× | (28.48%) |
| FY2020 | 19.2× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2019 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Sep 2026 | 5.2× | 94.26% |
| Jun 2026 | 2.7× | 4.72% |
| Mar 2026 | 2.6× | 13.58% |
| Dec 2025 | 2.3× | (20.19%) |
| 24 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| OFIX ORTHOFIX MEDICAL INC. compare | 0.6× |
| VMD Viemed Healthcare, Inc. compare | 1.1× |
| BWAY Brainsway Ltd. Sponsored ADR compare | 2.4× |
| MOBI Mobia Medical, Inc compare | 4.6× |
| MASS 908 Devices Inc. compare | 4.9× |
| SI Shoulder Innovations, Inc. compare | 5.4× |
| RCEL Avita Medical Inc. | 6.7× |
| SSII SS Innovations International, Inc. compare | 7.1× |
| CV CapsoVision, Inc. compare | 21.5× |
| Medical Devices industry median | 2.7× |
| Healthcare sector median | 3.5× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)